Trinity Biotech is pleased to announce that its landmark, high sensitivity Meritas® Troponin I (TnI) point-of-care (POC) test has obtained CE marking. It is now the only POC product capable of meeting all the guidelines stipulated by the world’s leading cardiac organizati...
|